Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital and industry converge at Campus Grand Parc.

BXLS funds innovation within the life sciences sector. Credit: Vector mall / Shutterstock.com. Private investment platform Blackstone closed a funding raise that has brought in $6.3bn in capital to ...

WHO is sponsoring a trial testing drugs for Bundibugyo virus, while adding the first Ebola diagnostic test to its emergency use list.

SK bioscience is set to lead the Gates Foundation-funded ROTOR project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.

The UK-US pharmaceuticals deal could cost the National Health Service (NHS) around £45bn ($60bn) within a decade and divert resources away from essential services, an analysis has suggested. The UK ...

The EC has granted approval for Novartis’ Itvisma as a treatment for children two years and older, teenagers, and adults who have 5q SMA with a bi-allelic mutation in the SMN1 gene.

Ipsen’s Memo acquisition is the second the former has signed this week alone, following its blockbuster Kartos buyout on 29 June.

Anthropic launches Claude Science as big tech companies increasingly eye expansion in the wider healthcare and life sciences space.

The industry looks set to continue a preference for European outsourcing facilities as national tax systems exert influence.

Eli Lilly’s retatrutide has crossed the 30% weight loss benchmark in some patients. Where do GLP-1RAs go from here?

Our editorial team delve into the key takeaways from the 2026 HLTH Europe conference and the 2026 BIO International Convention.

The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop.